Clinical Trial Update: 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating 3-AP for previously untreated locally recurrent or metastatic renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• 3-AP

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED